Actimis Spinout Raises $3 Million
Axikin Pharmaceuticals Inc., a San Diego-based developer of small-molecule therapeutics for respiratory and inflammatory diseases, has raised $3 million in Series A funding. Sanderling Ventures led the round, and was joined by Mitsui & Co. Venture Partners. Axikin was formed as a spinout from Actimis Pharmaceuticals.
22 January 2009•3 mins read
